Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Clinical Medicine | 1 | 2020 | 21 | 0.710 |
Why?
|
| Cold Temperature | 1 | 2020 | 80 | 0.680 |
Why?
|
| Rhinitis | 1 | 2020 | 38 | 0.660 |
Why?
|
| Authorship | 1 | 2018 | 29 | 0.580 |
Why?
|
| Ethics, Research | 1 | 2018 | 50 | 0.580 |
Why?
|
| Schools, Medical | 1 | 2018 | 114 | 0.570 |
Why?
|
| Research Personnel | 1 | 2018 | 117 | 0.540 |
Why?
|
| Publishing | 1 | 2018 | 108 | 0.540 |
Why?
|
| Social Behavior | 1 | 2018 | 207 | 0.530 |
Why?
|
| Clinical Competence | 2 | 2018 | 973 | 0.520 |
Why?
|
| Research | 1 | 2018 | 263 | 0.520 |
Why?
|
| Faculty, Medical | 1 | 2018 | 266 | 0.480 |
Why?
|
| Curriculum | 1 | 2018 | 718 | 0.420 |
Why?
|
| Quality of Life | 1 | 2018 | 1923 | 0.300 |
Why?
|
| Lipoprotein Lipase | 4 | 1992 | 54 | 0.250 |
Why?
|
| Remedial Teaching | 1 | 2004 | 4 | 0.240 |
Why?
|
| Clinical Clerkship | 1 | 2004 | 90 | 0.220 |
Why?
|
| Internal Medicine | 1 | 2004 | 147 | 0.210 |
Why?
|
| Anti-Bacterial Agents | 2 | 2024 | 2393 | 0.200 |
Why?
|
| Observation | 1 | 2020 | 42 | 0.180 |
Why?
|
| Anti-Infective Agents | 1 | 2023 | 266 | 0.180 |
Why?
|
| Housing | 1 | 2020 | 58 | 0.170 |
Why?
|
| Medical Futility | 1 | 2018 | 36 | 0.150 |
Why?
|
| Seasons | 1 | 2020 | 307 | 0.150 |
Why?
|
| Students, Medical | 2 | 2018 | 361 | 0.150 |
Why?
|
| Publications | 1 | 2018 | 33 | 0.150 |
Why?
|
| Bibliometrics | 1 | 2018 | 29 | 0.150 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 1997 | 16 | 0.150 |
Why?
|
| Italy | 1 | 2018 | 111 | 0.150 |
Why?
|
| Government Regulation | 1 | 2018 | 42 | 0.150 |
Why?
|
| Employment | 1 | 2018 | 67 | 0.140 |
Why?
|
| Nephrotic Syndrome | 1 | 1997 | 47 | 0.140 |
Why?
|
| Kidney Glomerulus | 1 | 1997 | 80 | 0.140 |
Why?
|
| Proteinuria | 1 | 1997 | 110 | 0.140 |
Why?
|
| Physical Examination | 1 | 2018 | 163 | 0.140 |
Why?
|
| Educational Status | 1 | 2018 | 270 | 0.140 |
Why?
|
| Universities | 1 | 2018 | 128 | 0.140 |
Why?
|
| Personnel Selection | 1 | 2018 | 63 | 0.140 |
Why?
|
| Humans | 18 | 2024 | 123103 | 0.130 |
Why?
|
| Hyperlipoproteinemia Type I | 2 | 1992 | 5 | 0.120 |
Why?
|
| Adult | 6 | 2024 | 29009 | 0.120 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 428 | 0.120 |
Why?
|
| Cinnamates | 1 | 1994 | 15 | 0.110 |
Why?
|
| Communication | 1 | 2018 | 513 | 0.110 |
Why?
|
| Serine | 2 | 1991 | 172 | 0.110 |
Why?
|
| Retroviridae | 1 | 1994 | 194 | 0.110 |
Why?
|
| Lipase | 2 | 1992 | 88 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 1 | 1997 | 434 | 0.100 |
Why?
|
| Nerve Growth Factors | 3 | 1996 | 72 | 0.090 |
Why?
|
| Mental Disorders | 1 | 2018 | 826 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 1994 | 940 | 0.090 |
Why?
|
| Neuroma, Acoustic | 1 | 1989 | 29 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1989 | 102 | 0.080 |
Why?
|
| Female | 7 | 2024 | 65514 | 0.070 |
Why?
|
| Male | 8 | 2024 | 60129 | 0.070 |
Why?
|
| Chromosome Aberrations | 2 | 1991 | 614 | 0.070 |
Why?
|
| Molecular Sequence Data | 7 | 1994 | 3867 | 0.070 |
Why?
|
| Cloning, Molecular | 5 | 1994 | 892 | 0.070 |
Why?
|
| Hippocampus | 3 | 1995 | 819 | 0.060 |
Why?
|
| Aged | 2 | 2024 | 19093 | 0.060 |
Why?
|
| Prescription Drug Overuse | 1 | 2024 | 3 | 0.060 |
Why?
|
| Middle Aged | 3 | 2024 | 25992 | 0.060 |
Why?
|
| Transfection | 3 | 1996 | 1068 | 0.060 |
Why?
|
| Mutation | 4 | 1992 | 5767 | 0.060 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 3664 | 0.060 |
Why?
|
| Amino Acid Sequence | 6 | 1994 | 2695 | 0.050 |
Why?
|
| Prescriptions | 1 | 2023 | 40 | 0.050 |
Why?
|
| Gene Transfer Techniques | 2 | 1994 | 357 | 0.050 |
Why?
|
| Antimicrobial Stewardship | 1 | 2024 | 83 | 0.050 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1994 | 368 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2004 | 449 | 0.050 |
Why?
|
| Insurance, Health | 1 | 2023 | 138 | 0.050 |
Why?
|
| Base Sequence | 5 | 1994 | 3091 | 0.050 |
Why?
|
| Educational Measurement | 1 | 2004 | 324 | 0.050 |
Why?
|
| Catalysis | 2 | 1991 | 125 | 0.050 |
Why?
|
| Binding Sites | 2 | 1992 | 1292 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2024 | 713 | 0.040 |
Why?
|
| Septal Nuclei | 2 | 1994 | 14 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2024 | 752 | 0.040 |
Why?
|
| DNA | 3 | 1992 | 1588 | 0.040 |
Why?
|
| Liposomes | 2 | 1994 | 169 | 0.040 |
Why?
|
| Cardiomegaly | 1 | 1997 | 133 | 0.030 |
Why?
|
| Neurofilament Proteins | 1 | 1996 | 28 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 4 | 1995 | 1584 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 1075 | 0.030 |
Why?
|
| Restriction Mapping | 2 | 1992 | 188 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3369 | 0.030 |
Why?
|
| Neurofibrils | 1 | 1995 | 2 | 0.030 |
Why?
|
| Translocation, Genetic | 2 | 1994 | 351 | 0.030 |
Why?
|
| Blast Crisis | 1 | 1994 | 17 | 0.030 |
Why?
|
| RNA, Messenger | 4 | 1995 | 2809 | 0.030 |
Why?
|
| Hygromycin B | 1 | 1994 | 2 | 0.030 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1994 | 98 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 1994 | 129 | 0.030 |
Why?
|
| Luciferases | 1 | 1994 | 137 | 0.030 |
Why?
|
| Pedigree | 3 | 1992 | 1576 | 0.030 |
Why?
|
| Lipids | 1 | 1996 | 514 | 0.030 |
Why?
|
| Hemodynamics | 1 | 1997 | 844 | 0.030 |
Why?
|
| RNA Splicing | 1 | 1994 | 224 | 0.030 |
Why?
|
| Drug Resistance | 1 | 1994 | 255 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1993 | 171 | 0.030 |
Why?
|
| Chylomicrons | 1 | 1992 | 8 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 135 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 287 | 0.020 |
Why?
|
| Tryptophan | 1 | 1992 | 90 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1992 | 316 | 0.020 |
Why?
|
| Turkey | 1 | 1991 | 58 | 0.020 |
Why?
|
| Pancreas | 1 | 1992 | 211 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1994 | 548 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 1991 | 75 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1991 | 396 | 0.020 |
Why?
|
| Glycine | 1 | 1991 | 167 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 1994 | 668 | 0.020 |
Why?
|
| Arginine | 1 | 1992 | 303 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1991 | 567 | 0.020 |
Why?
|
| Animals | 7 | 1996 | 33792 | 0.020 |
Why?
|
| Cells, Cultured | 4 | 1996 | 3040 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1991 | 833 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 1995 | 1112 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1994 | 532 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1992 | 1386 | 0.020 |
Why?
|
| Rats | 4 | 1996 | 3651 | 0.020 |
Why?
|
| Rhabdomyosarcoma | 1 | 1991 | 200 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 1991 | 464 | 0.020 |
Why?
|
| United States | 1 | 2023 | 10651 | 0.020 |
Why?
|
| Cell Line | 1 | 1992 | 2771 | 0.020 |
Why?
|
| Alleles | 1 | 1991 | 1603 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 1994 | 2055 | 0.020 |
Why?
|
| Obesity | 1 | 1997 | 2230 | 0.020 |
Why?
|
| Exons | 3 | 1994 | 794 | 0.020 |
Why?
|
| Liver | 1 | 1992 | 1734 | 0.020 |
Why?
|
| Transcription Factors | 1 | 1994 | 2585 | 0.010 |
Why?
|
| Chromosome Banding | 2 | 1994 | 139 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1996 | 1214 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 1994 | 757 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 1996 | 1688 | 0.010 |
Why?
|
| Brain | 1 | 1993 | 2967 | 0.010 |
Why?
|
| Mice | 2 | 1994 | 17537 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1995 | 46 | 0.010 |
Why?
|
| Galactosidases | 1 | 1994 | 7 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1994 | 27 | 0.010 |
Why?
|
| DNA Probes | 1 | 1994 | 123 | 0.010 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 1994 | 34 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1994 | 40 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1994 | 84 | 0.010 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 1995 | 117 | 0.010 |
Why?
|
| Karyotyping | 1 | 1994 | 330 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1993 | 80 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1996 | 1610 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1994 | 810 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1995 | 1100 | 0.010 |
Why?
|
| Asparagine | 1 | 1992 | 22 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1993 | 657 | 0.010 |
Why?
|
| Codon | 1 | 1992 | 96 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1994 | 764 | 0.010 |
Why?
|
| Polyploidy | 1 | 1991 | 15 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1993 | 371 | 0.010 |
Why?
|
| Introns | 1 | 1992 | 301 | 0.010 |
Why?
|
| Glutamine | 1 | 1992 | 195 | 0.010 |
Why?
|
| Adolescent | 1 | 1989 | 19094 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1993 | 255 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1991 | 1061 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1991 | 309 | 0.000 |
Why?
|
| Chromosome Deletion | 1 | 1991 | 638 | 0.000 |
Why?
|
| Gene Expression | 1 | 1992 | 1565 | 0.000 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1991 | 544 | 0.000 |
Why?
|
| Time Factors | 1 | 1994 | 6219 | 0.000 |
Why?
|
| Signal Transduction | 1 | 1993 | 4493 | 0.000 |
Why?
|
| Child | 1 | 1991 | 24228 | 0.000 |
Why?
|